Gastric Bypass Lowers Risk for Heart Disease

Susan Farley
Published Online: Saturday, October 1, 2005

A study from Stanford University determined that gastric bypass surgery for the treatment of obesity lowers the risk of heart disease even more than previously reported. Using 3 measures to determine heart disease risk?C-reactive protein, lipoprotein A, and homocysteine?as well as cholesterol levels, researchers studied 371 patients pre-and postsurgery. Patients showed improvements to normal range in all measures.

John Morton, MD, MPH, MHA, assistant professor of surgery at Stanford, said that using statins, considered the most effective nonsurgical treatment for heart disease, lowers C-reactive protein by ~16%. "We found that gastric bypass lowered it by 50%," he said. Gastric bypass surgery, reduces the size of the stomach so that patients have to eat less, and it also removes a long stretch of small intestine so that fewer nutrients are absorbed.

Ms. Farley is a freelance medical writer based in Wakefield, RI.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues